Pill Mill Mania…Or What I Used to Say at Work – Pill Millin’

When I accepted my transfer to DEA Diversion in Houston, I had absolutely no idea that my vocabulary – and my career - were about to change forever. All I knew was that I was leaving the Valley, aka the Rio Grande Valley. I was thankful for my time down there, but my career was going nowhere, and I remained dormant for eight long years…eight years too long for me.

When I accepted the offer for the Houston office, I spent the next 12 weeks at the DEA Academy in Quantico learning an entirely new profession.

After graduating from the academy, I headed back to Texas to get my life in order before reporting to the Houston office. It was there that I learned the basics of Diversion and met individuals in upper management, supervisors, and fellow Diversion Investigators (DIs) who would help shape me into the Investigator I became.

I knew nothing about pill mill pharmacies, pill mill doctors, or Drug Trafficking Organizations (DTOs). At first, it was all incredibly overwhelming, so I did what I thought was the smartest thing I could do: I stayed quiet, listened, observed, and absorbed everything around me like a sponge.

A typical day in the office felt like stepping into another world. My co-workers tossed around acronyms as if they were speaking an entirely different language. One minute we were reviewing spreadsheets and calculating dosage units; the next we were analyzing covert surveillance, dissecting inspection files, discussing active investigations, conducting strategy meetings, or processing evidence and controlled substances. No two days were ever the same, and every day brought another lesson.

It didn’t take long before I learned what a “pill mill” was. I also learned it wasn’t a phrase anyone wanted associated with their practice. Once you work enough investigations involving rogue prescribers and pharmacies, the phrase becomes part of your vocabulary. Before long, if I came across a pharmacy or doctor exhibiting all the classic red flags, I would tell my colleagues, “Looks like we got some pill millin’ going on.” It was dark humor born from the work we did, but behind the joke was a very serious reality. Every investigation had the potential to uncover conduct that endangered the public by diverting dangerous controlled substances into the illicit market.

By 2017 and into 2018, the usual suspects being diverted throughout Houston were Hydrocodone 10-325 mg, Alprazolam 2 mg, and Soma 350 mg…a combination commonly referred to on the street as “The Houston Cocktail”. It seemed like nearly every investigation involved one, if not all three of those controlled substances.

Then sometime in 2018, everything changed.

Talk about throwing a wrench into things.

Almost overnight, Oxycodone 30 mg seemed to explode onto the scene. It was as if someone had flipped a light switch. Suddenly, it was everywhere. Doctors were prescribing it, pharmacies were dispensing it, and investigators throughout the office began seeing it case after case. We all looked at each other like deer in the headlights, wondering, “Where did this come from?”

Before long, we realized this wasn’t an isolated trend – it was a fundamental shift in the diversion landscape. Cases that had once centered around the Houston Cocktail were now increasingly revolving around Oxycodone 30 mg, and the volume of investigations reflected it.

It wasn’t unusual to encounter physicians prescribing 110-120 tablets of Oxycodone 30 mg per patient. Many of those patients would then take their prescriptions to pharmacies willing to fill them, where the cost often exceeded $1,000 per prescription when paid in cash. As investigators, we began seeing the same prescribing patterns, the same pharmacies, and, in many cases, the same individuals appearing across multiple investigations.

It didn’t take long to understand why. At the time, Oxycodone 30 mg tablets were bringing approximately $30 per pill on the street, making them one of the highest-value and most sought-after controlled substances on the illicit market. That demand created a powerful financial incentive for unethical prescribers, complicit pharmacies, brokers, and traffickers to exploit the system.

During my first Oxycodone investigation, I remember reviewing physicians’ prescribing patterns. Every prescription was for 110 tablets of Oxycodone 30 mg, accompanied by the same three non-controlled medications - amlodipine, docusate, and Biofreeze.

Every patient.

Every prescription.

Every single time.

You didn’t need another physician's opinion to know something wasn’t right. How were dozens of unrelated patients all receiving the exact same combination of medications? I remember saying out loud to myself, “What in the Blues Clues is going on?!” I started laying the prescriptions side by side, looking for patterns. It didn’t take long before the similarities jumped off the page.

The names were different. The birthdays were different. The addresses were different, but the prescriptions looked like they had been copied and pasted.

That first Oxycodone investigation changed the way I looked at every case that followed. It taught me that diversion isn’t uncovered by finding one smoking gun – it’s uncovered by recognizing patterns, asking questions, and refusing to ignore the details that everyone else overlooks.

Those lessons stayed with me throughout my career and continue to shape the way I approach compliance today. The goal has never been to catch people doing something wrong. It’s to help legitimate healthcare professionals build systems that prevent diversion before it ever happens.

And if there’s one thing I learned during those years in Houston, it’s this:

Sometimes the biggest investigations begin with one simple thought…

“What in the Blues Clues is going on?”

Or, as we’d eventually say around the office…

Looks like we’ve got some pill millin’ going on.